Zhejiang Jingxin Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange:002020.SZ

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🧬 Biotechnology

🔬 Clinical Trials

💊 Drugstores & Retail Pharmacies

💻 Telehealth

Location

China

Market Cap

USD 1.57 B

Share Price

USD 1.81

Avg Daily Volume

12,922,370

Change (1 day)

-0.62%

Change (1 year)

22.64%

Change (YTD)

3.05%

Zhejiang Jingxin Pharmaceutical Co., Ltd. Operating Income Margin for the year ending December 31, 2024: 20.29%

Zhejiang Jingxin Pharmaceutical Co., Ltd. Operating Income Margin is 20.29% for the year ending December 31, 2024, a 13.60% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.

Zhejiang Jingxin Pharmaceutical Co., Ltd. Operating Income Margin for the year ending December 31, 2023 was 17.86%, a -10.79% change year over year.
Zhejiang Jingxin Pharmaceutical Co., Ltd. Operating Income Margin for the year ending December 31, 2022 was 20.02%, a -3.64% change year over year.
Zhejiang Jingxin Pharmaceutical Co., Ltd. Operating Income Margin for the year ending December 31, 2021 was 20.77%, a -11.58% change year over year.
Zhejiang Jingxin Pharmaceutical Co., Ltd. Operating Income Margin for the year ending December 31, 2020 was 23.49%, a 42.29% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Operating Income Margin	Gross Profit Margin	EBIT Margin	EBITDA Margin

Shenzhen Stock Exchange: 002020.SZ

Zhejiang Jingxin Pharmaceutical Co., Ltd.

CEO	Mr. Lv Gang
IPO Date	July 15, 2004
Location	China
Headquarters	No. 800, East Road
Employees	3,909
Sector	🏥 Health Care
Industries Pharmaceuticals 🧬 Biotechnology 🔬 Clinical Trials 💊 Drugstores & Retail Pharmacies 💻 Telehealth

Description

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in China. The company offers APIs, antihypertensive products, antibiotics, quinolones, gastrointestinal promotions, antidiabetics, antipileptics, antihistamines, H+ pump depressants, antihyper cholesterolemia products, histamine H2 receptor blokades, antihyper cholesterolemirs, antidepressants, cephalosporin products, and biopharma products. It also provides diagnostic medical displays, surgical medical displays, clinical medical displays, medical large screens, medical integrated machines, ultrasonic medical displays, and other products. The company was formerly known as Zhejiang Jingxin Pharmaceutical Factory and changed its name to Zhejiang Jingxin Pharmaceutical Co., Ltd. in 2000. Zhejiang Jingxin Pharmaceutical Co., Ltd. was founded in 1974 and is headquartered in Xinchang, China.